China Sanjiang Fine Chemicals Company Limited (FRA:8C9)
Germany · Delayed Price · Currency is EUR 0.4800
-0.0180 (-3.61%)
At close: Jan 27, 2026
FRA:8C9 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 19,452 | 19,586 | 13,128 | 8,818 | 9,499 | 8,323 | |
Revenue Growth (YoY) | 9.42% | 49.19% | 48.88% | -7.17% | 14.13% | -9.45% |
Cost of Revenue | 18,334 | 18,510 | 12,960 | 8,888 | 8,864 | 6,693 |
Gross Profit | 1,118 | 1,076 | 168.77 | -70.38 | 634.52 | 1,630 |
Selling, General & Admin | 252.6 | 235.61 | 201.46 | 201.31 | 282.94 | 419.52 |
Other Operating Expenses | 19.45 | 26.35 | 3.67 | 543.19 | 457.21 | 142.99 |
Operating Expenses | 272.85 | 262.75 | 207.91 | 738.49 | 739.4 | 559.74 |
Operating Income | 845.33 | 812.98 | -39.14 | -808.87 | -104.88 | 1,070 |
Interest Expense | -393.92 | -414.66 | -214.9 | -168.32 | -131.33 | -110.02 |
Interest & Investment Income | 48.88 | 73.88 | 139.72 | 198.55 | 74.17 | 131.98 |
Currency Exchange Gain (Loss) | -44.66 | -77.22 | -26.73 | -125.43 | 35 | 80.25 |
Other Non Operating Income (Expenses) | 264.66 | 206.14 | 176.58 | 625.98 | 564.08 | 188.82 |
EBT Excluding Unusual Items | 720.29 | 601.13 | 35.52 | -278.1 | 437.03 | 1,361 |
Merger & Restructuring Charges | - | - | - | - | -0.02 | - |
Gain (Loss) on Sale of Investments | - | - | -16.22 | -30.48 | 5.17 | 30.65 |
Gain (Loss) on Sale of Assets | -7 | -53.98 | -32.9 | - | - | - |
Asset Writedown | - | - | -193.61 | -55.91 | - | - |
Other Unusual Items | - | - | 227.42 | - | - | - |
Pretax Income | 713.29 | 547.15 | 20.21 | -364.48 | 442.18 | 1,392 |
Income Tax Expense | 31.69 | 13.21 | -23.93 | -10.03 | 66.03 | 177.85 |
Earnings From Continuing Operations | 681.6 | 533.94 | 44.13 | -354.45 | 376.15 | 1,214 |
Minority Interest in Earnings | -1.97 | -1.39 | 47.34 | 46.57 | 4.46 | -91.27 |
Net Income | 679.63 | 532.55 | 91.48 | -307.88 | 380.61 | 1,123 |
Net Income to Common | 679.63 | 532.55 | 91.48 | -307.88 | 380.61 | 1,123 |
Net Income Growth | 209.75% | 482.17% | - | - | -66.11% | 104.64% |
Shares Outstanding (Basic) | 1,158 | 1,158 | 1,167 | 1,176 | 1,176 | 1,181 |
Shares Outstanding (Diluted) | 1,158 | 1,158 | 1,167 | 1,176 | 1,176 | 1,181 |
Shares Change (YoY) | 0.02% | -0.76% | -0.80% | - | -0.40% | -0.09% |
EPS (Basic) | 0.59 | 0.46 | 0.08 | -0.26 | 0.32 | 0.95 |
EPS (Diluted) | 0.59 | 0.46 | 0.08 | -0.26 | 0.32 | 0.95 |
EPS Growth | 209.67% | 486.62% | - | - | -65.97% | 104.83% |
Free Cash Flow | 275.46 | -398.12 | -1,286 | -3,521 | -834.29 | -209.13 |
Free Cash Flow Per Share | 0.24 | -0.34 | -1.10 | -2.99 | -0.71 | -0.18 |
Dividend Per Share | - | - | - | - | 0.151 | 0.358 |
Dividend Growth | - | - | - | - | -57.88% | 60.13% |
Gross Margin | 5.75% | 5.49% | 1.29% | -0.80% | 6.68% | 19.59% |
Operating Margin | 4.35% | 4.15% | -0.30% | -9.17% | -1.10% | 12.86% |
Profit Margin | 3.49% | 2.72% | 0.70% | -3.49% | 4.01% | 13.49% |
Free Cash Flow Margin | 1.42% | -2.03% | -9.79% | -39.93% | -8.78% | -2.51% |
EBITDA | 1,808 | 1,848 | 497.1 | -285 | 388.69 | 1,638 |
EBITDA Margin | 9.30% | 9.44% | 3.79% | -3.23% | 4.09% | 19.68% |
D&A For EBITDA | 963.07 | 1,035 | 536.24 | 523.87 | 493.58 | 567.41 |
EBIT | 845.33 | 812.98 | -39.14 | -808.87 | -104.88 | 1,070 |
EBIT Margin | 4.35% | 4.15% | -0.30% | -9.17% | -1.10% | 12.86% |
Effective Tax Rate | 4.44% | 2.41% | - | - | 14.93% | 12.78% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.